Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Feeling sick can be "all in the head" for people with inflammatory disorders or for those receiving immunotherapy, say Robert Dantzer and Keith Kelley, professors in the department of animal sciences at the University of Illinois at Urbana-Champaign.

29 Jul 2004

Millions of American osteoporosis sufferers remain undiagnosed and untreated

Osteoporosis is a serious health condition that affects over 44 million Americans. The human and economic costs for this condition may account for some $17 billion in direct expenditures in hospitals and nursing homes and that annual expense is expected to triple by 2040.

26 Jul 2004

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics, a privately held biopharmaceutical company, said today it has submitted applications to the Ethics Committee and Ministry of Health (BfArM) in Germany to begin Phase II clinical trials for its two most advanced projects, YSIL6 for rheumatoid arthritis and YSTH2 for asthma.

26 Jul 2004

Tai Chi helps keep arthritis sufferers on their feet

The traditional Chinese martial art of Tai Chi has been said to produce a variety of health benefits for older adults.

21 Jul 2004

Results of study have considerable implications for the management of people with rheumatoid arthritis

Results of a UK study in this week’s issue of THE LANCET suggest that intensive monthly outpatient treatment with antirheumatic drugs and steroid injections can substantially improve patients’ symptoms of rheumatoid arthritis compared with standard three-month outpatient treatment.

15 Jul 2004

A new protocol for bone marrow transplants

A new protocol for bone marrow transplants, which does not require the destruction of the recipient’s immune system before transfer of the new bone marrow, is described by a group of Oxford scientists

5 Jul 2004

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people or 10% of the 500,000 people in the U.S with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery for coverage of life saving drugs.

26 Jun 2004

Tommy G. Thompson has announced a new Medicare program that will save seniors and the disabled substantial money

HHS Secretary Tommy G. Thompson today announced a new Medicare demonstration program that will save seniors and persons with disabilities substantial money

24 Jun 2004

Genetic variation that doubles the risk for rheumatoid arthritis

A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).

24 Jun 2004

Statins could be effective in relieving symptoms of rheumatoid arthritis

Results of a UK study in this week's issue of THE LANCET suggest that the anti-inflammatory effect of statins (a class of cholesterol-lowering drugs) could be effective in relieving symptoms of rheumatoid arthritis.

17 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Cannabis extract drug may help patients with rheumatoid arthritis

The multi centre double blind, randomised, parallel group study in 58 patients assessed the efficacy, safety and tolerability of Sativex®, a whole plant medicinal cannabis extract, compared with placebo for the treatment of pain caused by Rheumatoid Arthritis. Study medication was administered by means of a spray into the mouth as an evening dose only and measures were assessed the following day.

11 Jun 2004

Enbrel therapy allowed more rheumatoid arthritis patients to achieve clinical remission

New results from TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) demonstrated that Enbrel® (etanercept) therapy allowed significantly more rheumatoid arthritis (RA) patients to achieve clinical remission at two years compared to patients treated with methotrexate alone.

11 Jun 2004

High vitamin C intake may protect against rheumatoid arthritis

A high vitamin C intake may protect against the development of painful widespread rheumatoid arthritis indicates research published in the Annals of the Rheumatic Diseases.

10 Jun 2004

Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma

Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.

7 Jun 2004

Lack of funding and staff in the UK hinders patient care

Doctors across the UK are leading innovative approaches to patient care but are blocked from developing their projects further by lack of funding and staff according to a new publication launched today (3 June) by the BMA.

3 Jun 2004

Patients prescribed medication for long term illness rapidly stop taking their medicines

Many patients prescribed a medicine for a long term condition, such as asthma or heart disease, rapidly stop taking their medicines as prescribed, reveals research in Quality and Safety in Health Care.

1 Jun 2004

Using gene therapy to fight rheumatoid arthritis

Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent “circling the lot” and unable to cause pain, swelling and possible joint damage.

21 May 2004

New treatment for dry eye syndrome (keratoconjunctivitis sicca)

Researchers in the department of ophthalmology at the University of Arizona College of Medicine in Tucson played an important role in the development of Restasis, the first alternative to artificial tears for the treatment of dry eye syndrome.

21 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Millions of American osteoporosis sufferers remain undiagnosed and untreated

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Tai Chi helps keep arthritis sufferers on their feet

Results of study have considerable implications for the management of people with rheumatoid arthritis

A new protocol for bone marrow transplants

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

Tommy G. Thompson has announced a new Medicare program that will save seniors and the disabled substantial money

Genetic variation that doubles the risk for rheumatoid arthritis

Statins could be effective in relieving symptoms of rheumatoid arthritis

Results from study of Rituxan in rheumatoid arthritis show promise

Cannabis extract drug may help patients with rheumatoid arthritis

Enbrel therapy allowed more rheumatoid arthritis patients to achieve clinical remission

High vitamin C intake may protect against rheumatoid arthritis

Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma

Lack of funding and staff in the UK hinders patient care

Patients prescribed medication for long term illness rapidly stop taking their medicines

Using gene therapy to fight rheumatoid arthritis

New treatment for dry eye syndrome (keratoconjunctivitis sicca)

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Newsletters you may be interested in